Pathway Therapeutics
Employee Participants1
Total Rating18
Revenue$0
Pathway Therapeutics develops selective inhibitors of PI3-kinase and mTOR for the treatment of cancer and inflammatory diseases. Read More
Headquarters 409 Illinois Street, San Francisco, CA, USA
Website http://pathwaytx.com
70/100